医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Seychelle Reports Expanded Distribution in China and Japan for Its New Radiological, Advanced and Alkaline (pH) Filters

2013年12月16日 PM11:25
このエントリーをはてなブックマークに追加


 

SAN JUAN CAPISTRANO, Calif.

Seychelle Water Filtration Products, a DBA of Seychelle Environmental Technologies, Inc. (Seychelle) (OTCQB:SYEV), a worldwide leader in the development, assembly and sale of proprietary portable water filtration bottles made several key announcements today relating to its expanded distribution in China and Japan for its new filtration products.

Carl Palmer, President, Founder and Chairman stated that, “We are pleased to announce that we have made meaningful distribution gains in Asia with the appointment of four new distributors in China and two in Japan. There is great concern in the region about the quality of drinking water, and great interest in Seychelle’s new filter products; our clear 20 oz pull top sports bottles with the capability of removing radiological and microbiological contaminants; and our new clear 25 oz pull top bottle which removes not only radiologicals, but also increases the alkalinity (pH) of the filtered water. Mr. Palmer went on to say that, “With over 1.6 billion people in China and Japan alone, we feel that our new products will go a long way to improve the quality of life for many people – while benefiting Seychelle shareholders and should increase our revenues and earnings in January and February to close out the current fiscal year and continuing on into the next fiscal year.”

Dick Parsons, Chief Executive Officer, said that, “We continue to be pleased with our US Direct Response TV test program that features our new clear 20 oz pull top sports bottle, and are developing plans to roll it out in the US in early 2014. In just a few days last week, TV sales generated over $200,000 in revenue! The new bottle has many attractive consumer features and is competitively priced. It is a far superior performing product in the removal of a number of contaminants compared to Brita, Bobble and Rubbermaid filters bottles. We are in talks now with several manufacturers’ representatives developing go-to-market strategies for major retailers such as Target, Wal-Mart and Costco.” Further, Mr. Parsons said, “We also have designed three new products which we believe are unique in design and functionality, and plan to introduce them into the US in the first part of 2014. We believe that they will be important revenue and earnings contributors next fiscal year. Finally, we have been working with our suppliers to reduce costs for some of our high volume products and are pleased to report that we anticipate savings of up to $300,000 in fiscal 2015 that should contribute to improved earnings.”

With Seychelle portable water filtration, consumers can drink, with complete confidence, perfectly filtered water that is great-tasting from a variety of sources – the tap, rivers, streams, ponds or creeks. The regular filter works for water from the tap while the standard and advanced filters are needed for most outdoor uses. The proprietary Seychelle Ionic Adsorption Micron Filtration (IAMF) has been tested extensively by Independent Government Laboratories in the US and throughout the world to strict EPA/ANSI protocols and NSF Standards 42 and 53 by Broward Testing Laboratories.

“Perfectly Filtered – Great Taste – Healthier Life”

Note to Investors

This press release may contain certain forward-looking information about the Seychelle’s business prospects/projections. These are based upon good-faith current expectations of Seychelle’s management. Seychelle makes no representation or warranty as to the attainability of such assumptions/projections. Investors are expected to conduct their own investigation with regard to Seychelle. Seychelle assumes no obligation to update the information in this press release. For more information, please visit www.seychelle.com or call (949) 234-1999.

CONTACT

Seychelle Environmental Technologies, Inc.
Dick Parsons,
949-234-1999
dickparsons@seychelle.com

同じカテゴリーの記事 

  • La Jolla Institute for Immunology and RevolKa started a Research Collaboration
  • U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
  • ESCMID Global 2024: Shionogi presents real-world data demonstrating efficacy of Fetcroja® / Fetroja® (cefiderocol) in critically ill patients with certain difficult-to-treat bacterial infections
  • Renesas’ New FemtoClock™ 3 Timing Solution Delivers Industry’s Lowest Power and Leading Jitter Performance of 25fs-rms
  • The Office of Health Economics: Adult Vaccination Programmes Deliver Socio-economic Benefits up to 19 Times Initial Investment, According to New Report